Cambient Family Office »

Vertex Pharmaceuticals Incorporated shares owned by Cambient Family Office

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cambient Family Office from 13F filings

Historical chart of Cambient Family Office investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cambient Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cambient Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $264k 582 453.34

More positions owned by Cambient Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Raytheon Technologies Corp (RTX)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Abbvie (ABBV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Index Fds Total Stk Mkt (VTI)
Palantir Technologies Cl A (PLTR)

View all positions for Cambient Family Office

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
FMR
Jennison Associates
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated